Exelon Corp: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 3, 2023 and accepted by EDGAR at May 3, 2023, 14:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $5.56bn | us-gaap:Revenues |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $1.11bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $134.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $669.0m | us-gaap:ProfitLoss |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 996,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-01 to 2023-03-31 | $484.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-01 to 2023-03-31 | $1.88bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-01-01 to 2023-03-31 | $358.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-03-31 | $522.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $7.78bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $96.92bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $8.09bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $71.86bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $38.73bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2023-03-31 | $1.31bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-03-31 | $25.07bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-03-31 | 994,568,998 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001109357-23-000040. Last ingested by Listed: Oct 30, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.